Apitegromab

Apitegromab Uses, Dosage, Side Effects, Food Interaction and all others data.

Apitegromab is under investigation in clinical trial NCT03921528 (An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy).

Trade Name Apitegromab
Generic Apitegromab
Apitegromab Other Names Apitegromab, Immunoglobulin g4 (234-proline), anti-(human progrowth differentiation factor 8) (human monoclonal srk-015 .gamma.4-chain), disulfide with human monoclonal srk-015 .lambda.-chain, dimer
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Apitegromab
Apitegromab

Innovators Monograph

You find simplified version here Apitegromab


*** Taking medicines without doctor's advice can cause long-term problems.
Share